QR Code

Characteristics of Adult Patients With Atopic Dermatitis Initiating Biologics and Janus Kinase Inhibitors in the CorEvitas Atopic Dermatitis Registry

ABSTRACT Background Biologics and Janus kinase inhibitors (JAKi) are two advanced systemic treatment options for patients with atopic dermatitis (AD). The decision to initiate one of these therapies is complex and may be driven by many factors. Objectives This cross‐sectional study described and eva...

Whakaahuatanga katoa

I tiakina i:
Ngā kaituhi matua: Eric L. Simpson, Linda Stein Gold, Seemal R. Desai, Alexandra K. Golant, Douglas DiRuggiero, Christian Fenske, Yolanda Muñoz Maldonado, Alvin H. Li, Zach Dawson, Kaylee Ho, Kayla Callahan, Gaia Gallo, Jonathan I. Silverberg
Hōputu: Artigo
Reo:Inglês
I whakaputaina: Wiley 2026-03-01
Rangatū:JEADV Clinical Practice
Ngā marau:
atopic dermatitis
biologics
JAK inhibitors
real‐world evidence
Urunga tuihono:https://doi.org/10.1002/jvc2.70153
Ngā Tūtohu: Tāpirihia he Tūtohu
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!

Ngā tūemi rite